SLAMF7 and Miyoshi myopathy: However, it may be beneficial and open new possibilities of using MM antigens that are not restricted to plasma cells and myeloma cells, especially antigens that are highly expressed on MM cells, but lower on healthy cells, such as CD138, CD38, and SLAMF7.